Praxis Precision Medicines (PRAX) Long-Term Investments (2024 - 2026)

Praxis Precision Medicines' Long-Term Investments history runs 3 years deep, the most recent figure standing at $660.9 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 358.88% year-over-year to $660.9 million; the TTM figure through Mar 2026 stood at $660.9 million (up 358.88% YoY), while the FY2025 annual figure was $326.8 million, up 324.57% from the prior year.
• Long-Term Investments was $660.9 million for Q1 2026 at Praxis Precision Medicines, up from $326.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $660.9 million in Q1 2026 to a low of $35.9 million in Q1 2024.
• Historically, Long-Term Investments has averaged $183.1 million across 3 years, with a median of $122.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Long-Term Investments surged 77.38% in 2025, then jumped 358.88% in 2026.
• A 3-year view of Long-Term Investments shows it stood at $77.0 million in 2024, then jumped by 324.57% to $326.8 million in 2025, then surged by 102.27% to $660.9 million in 2026.
• The last three Long-Term Investments figures came in at $660.9 million (Q1 2026), $326.8 million (Q4 2025), and $122.0 million (Q3 2025), per Business Quant data.